The Analysis of the Relationship between Multiple Myeloma Cells and Their Microenvironment
- PMID: 25561981
- PMCID: PMC4280399
- DOI: 10.7150/jca.10873
The Analysis of the Relationship between Multiple Myeloma Cells and Their Microenvironment
Abstract
The bone marrow microenvironment plays a key role in the stimulation of growth and survival of multiple myeloma (MM) cells. We investigated whether membrane microfragments (MFBs) exert a stimulatory effect on mesenchymal stem cell (MSC) gene expression or differentiation. MSCs from patients with multiple myeloma (MMBM-MSCs) proliferated at a slower rate than MSCs from healthy volunteers (BM-MSCs), and fewer MMBM-MSCs adhered to the substrate as compared to BM-MSCs. Phenotypic analysis revealed that MMBM-MSCs and BM-MSCs differed significantly in terms of their CD166 and CXCR4 expressions. In conclusion, our comparative analysis of mesenchymal cells from MM patients and healthy volunteers revealed differences in the genetic and phenotypic profiles of these two populations, their potential for osteodifferentiation, and expression of surface antigens. Moreover, we showed that membrane MFBs may alter the genetic profile of MSCs, leading to disorders of their osteodifferentiation, and interact with the WNT pathway via presentation of the DKK-1 protein.
Keywords: bone marrow; genotype; membrane microfragments; microenvironment; multiple myeloma; osteodifferentiation.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interest exists.
Figures





Similar articles
-
Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.Stem Cell Res Ther. 2017 Apr 26;8(1):102. doi: 10.1186/s13287-017-0555-9. Stem Cell Res Ther. 2017. PMID: 28446235 Free PMC article.
-
Expression of hsa-MIR-204, RUNX2, PPARγ, and BCL2 in Bone Marrow Derived Mesenchymal Stem Cells from Multiple Myeloma Patients and Normal Individuals.Cell J. 2017 Spring;19(Suppl 1):27-36. doi: 10.22074/cellj.2017.4480. Epub 2017 May 17. Cell J. 2017. PMID: 28580305 Free PMC article.
-
Microenvironment in neuroblastoma: isolation and characterization of tumor-derived mesenchymal stromal cells.BMC Cancer. 2018 Nov 27;18(1):1176. doi: 10.1186/s12885-018-5082-2. BMC Cancer. 2018. PMID: 30482160 Free PMC article.
-
Bone Marrow Mesenchymal Stromal Cells in Multiple Myeloma: Their Role as Active Contributors to Myeloma Progression.Cancers (Basel). 2021 May 22;13(11):2542. doi: 10.3390/cancers13112542. Cancers (Basel). 2021. PMID: 34067236 Free PMC article. Review.
-
Communication between bone marrow mesenchymal stem cells and multiple myeloma cells: Impact on disease progression.World J Stem Cells. 2023 May 26;15(5):421-437. doi: 10.4252/wjsc.v15.i5.421. World J Stem Cells. 2023. PMID: 37342223 Free PMC article. Review.
Cited by
-
Bone Marrow Stromal Cells-Induced Drug Resistance in Multiple Myeloma.Int J Mol Sci. 2020 Jan 17;21(2):613. doi: 10.3390/ijms21020613. Int J Mol Sci. 2020. PMID: 31963513 Free PMC article. Review.
-
Celastrol Attenuates the Invasion and Migration and Augments the Anticancer Effects of Bortezomib in a Xenograft Mouse Model of Multiple Myeloma.Front Pharmacol. 2018 May 3;9:365. doi: 10.3389/fphar.2018.00365. eCollection 2018. Front Pharmacol. 2018. PMID: 29773987 Free PMC article.
-
Mesenchymal Stromal Cells Can Regulate the Immune Response in the Tumor Microenvironment.Vaccines (Basel). 2016 Nov 8;4(4):41. doi: 10.3390/vaccines4040041. Vaccines (Basel). 2016. PMID: 27834810 Free PMC article. Review.
-
Stromal alterations in patients with monoclonal gammopathy of undetermined significance, smoldering myeloma, and multiple myeloma.Blood Adv. 2024 May 28;8(10):2575-2588. doi: 10.1182/bloodadvances.2023011632. Blood Adv. 2024. PMID: 38241490 Free PMC article.
-
Bone marrow-derived mesenchymal stem cells inhibit CD8+ T cell immune responses via PD-1/PD-L1 pathway in multiple myeloma.Clin Exp Immunol. 2021 Jul;205(1):53-62. doi: 10.1111/cei.13594. Epub 2021 May 7. Clin Exp Immunol. 2021. PMID: 33735518 Free PMC article.
References
-
- Derksen PW, de Gorter DJ, Meijer HP. et al. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma. Leukemia. 2003;17:764–74. - PubMed
-
- Gahrton G. New therapeutic targets in multiple myeloma. Lancet. 2004;364:1648–9. - PubMed
-
- Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267–74. - PubMed
-
- De Raeve HR, Vanderkerken K. The role of the bone marrow microenvironment in multiple myeloma. Histol Histopathol. 2005;20:1227–50. - PubMed
-
- Podar K, Tai YT, Lin BK. et al. Vascular endothelial growth factor-induced migration of multiple myeloma cells is associated with beta 1 integrin- and phosphatidylinositol 3-kinase-dependent PKC alpha activation. J Biol Chem. 2002;277:7875–81. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials